JY
YARW

Jeff Yass’s Yarrow Bioscience YARW Stock Holding History

Jeff Yass’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.4K Buy
2,379
+1,223
+106% +$39.7K ﹤0.01% 12649
2026
Q1 		$34.5K Sell
1,156
-851
-42% -$24.8K ﹤0.01% 12729
2025
Q4 		$58.2K Buy
2,007
+852
+74% +$17.1K ﹤0.01% 11699
2025
Q3 		$19.4K Sell
1,155
-1
-0.1% -$33 ﹤0.01% 12055
2025
Q2 		$95.4K Buy
1,156
+1
+0.1% +$65 ﹤0.01% 11825
2025
Q1 		$91.3K Sell
1,155
-262
-18% -$32.2K ﹤0.01% 11594
2024
Q4 		$237K Buy
1,417
+210
+17% +$27.5K ﹤0.01% 10337
2024
Q3 		$113K Buy
1,207
+1
+0.1% +$95 ﹤0.01% 10967
2024
Q2 		$119K Hold
1,206
– – ﹤0.01% 10894
2024
Q1 		$185K Hold
1,206
– – ﹤0.01% 10677
2023
Q4 		$141K Sell
1,206
-309
-20% -$48.2K ﹤0.01% 11031
2023
Q3 		$303K Sell
1,515
-13
-0.9% -$2.84K ﹤0.01% 9330
2023
Q2 		$310K Buy
1,528
+1,168
+324% +$311K ﹤0.01% 9369
2023
Q1 		$55.5K Buy
360
+342
+1,900% +$61.4K ﹤0.01% 11654
2022
Q4 		$2.47K Sell
18
-10
-36% -$2K ﹤0.01% 12115
2022
Q3 		$6K Buy
+28
New +$8.96K ﹤0.01% 12863
2022
Q2 		– Sell
-11
Closed -$7K – 14058
2022
Q1 		$7K Sell
11
-39
-78% -$23.2K ﹤0.01% 12789
2021
Q4 		$46K Buy
50
+34
+213% +$36.5K ﹤0.01% 12594
2021
Q3 		$20K Sell
16
-37
-70% -$71.8K ﹤0.01% 12548
2021
Q2 		$167K Buy
+53
New +$210K ﹤0.01% 11776
2021
Q1 		– Sell
-9
Closed -$65.3K – 12905
2020
Q4 		$54K Buy
9
+1
+13% +$6.28K ﹤0.01% 10733
2020
Q3 		$45K Buy
+8
New +$46.7K ﹤0.01% 10230
2020
Q2 		– Sell
-20
Closed -$193K – 11021
2020
Q1 		$193K Buy
+20
New +$314K ﹤0.01% 8737

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Jeff Yass's YARW Position: Q2 2026 in Review

Jeff Yass increased its Yarrow Bioscience (YARW) stake by 106% in Q2 2026, buying an estimated $39.7K and bringing the position to 2,379 shares worth $77.4K. The position accounts for ﹤0.01% of the portfolio, ranked #12649.

Jeff Yass first reported a position in YARW in Q1 2020 and has held it in 23 quarters since. The position peaked at $310K in Q2 2023. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Jeff Yass held 2,379 shares of Yarrow Bioscience worth $77.4K as of Q2 2026.
  • Jeff Yass bought 1,223 Yarrow Bioscience shares in Q2 2026, an estimated $39.7K.
  • Yarrow Bioscience made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12649 holding.
  • Jeff Yass first reported a position in Yarrow Bioscience in Q1 2020 and has held it in 23 quarters since.
  • Jeff Yass's Yarrow Bioscience position peaked at $310K in Q2 2023.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.